FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 01:13:13 06/07/2024 am IST | ||
| 0.006 EUR | -14.29% |
|
| Current month | -53.85% | ||
| 1 month | -57.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 0.006 | -14.29% |
| 04/24/04 | 0.007 | +16.67% |
| 03/24/03 | 0.006 | -25.00% |
| 02/24/02 | 0.008 | -27.27% |
| 01/24/01 | 0.011 | -15.38% |
Delayed Quote Deutsche Boerse AG
Last update July 06, 2024 at 01:13 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SU0HF5 |
| ISIN | DE000SU0HF50 |
| Date issued | 10/10/2023 |
| Strike | 56.67 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.2 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.4 € |
|---|---|
| Lowest since issue | 0.005 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
39.66
USD
Average target price
53.19
USD
Spread / Average Target
+34.13%
- Stock Market
- Certificates
- Certificat
